drugset / Trial / NCT05638893

Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients

NCT05638893

Phase 2/3 Completed 50 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to evaluate the possible efficacy and safety of addition of metformin to celecoxib in patients with knee osteoarthritis.

Timeline

Start
2021-02-01
Primary completion
2022-03-12
Completion
2022-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral
Background Celecoxib Other / unclassified 200 mg Oral

Indications